was successfully added to your cart.


Colorectal Oncology News

By May 21, 2019 May 27th, 2019 News

New Colorectal cancer targeted therapy combination shows promise

New SWOG study results show significantly better outcomes for patients with a treatment-resistant form of metastatic colorectal cancer when the BRAF inhibitor vemurafenib is added to a standard treatment. The findings, for the first time, point at an effective treatment for this deadly type of cancer. Click here to read the full article.